|
G3BP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.53390000000276E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.431700E-04 |
| Normal-vs-Stage2 |
1.765790E-02 |
| Normal-vs-Stage3 |
5.980500E-04 |
| Normal-vs-Stage4 |
3.577400E-03 |
| Stage1-vs-Stage2 |
8.319800E-01 |
| Stage1-vs-Stage3 |
5.022600E-01 |
| Stage1-vs-Stage4 |
7.302400E-01 |
| Stage2-vs-Stage3 |
8.363000E-01 |
| Stage2-vs-Stage4 |
9.734200E-01 |
| Stage3-vs-Stage4 |
8.392200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.837800E-04 |
| Normal-vs-AfricanAmerican |
5.94500000339337E-08 |
| Normal-vs-Asian |
8.556000E-02 |
| Caucasian-vs-AfricanAmerican |
5.837500E-04 |
| Caucasian-vs-Asian |
6.864400E-01 |
| AfricanAmerican-vs-Asian |
4.044200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.233390E-04 |
| Normal-vs-Female |
9.197800E-04 |
| Male-vs-Female |
7.399400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.475010E-03 |
| Normal-vs-Age(41-60Yrs) |
4.437400E-04 |
| Normal-vs-Age(61-80Yrs) |
9.009600E-04 |
| Normal-vs-Age(81-100Yrs) |
3.291800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.794800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.264000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.577400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.533600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.948800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.661800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.773170E-01 |
| Normal-vs-Grade 2 |
5.496000E-03 |
| Normal-vs-Grade 3 |
3.64529999999919E-05 |
| Normal-vs-Grade 4 |
1.458930E-03 |
| Grade 1-vs-Grade 2 |
9.595600E-01 |
| Grade 1-vs-Grade 3 |
4.703000E-01 |
| Grade 1-vs-Grade 4 |
5.475600E-01 |
| Grade 2-vs-Grade 3 |
9.278500E-02 |
| Grade 2-vs-Grade 4 |
2.479600E-01 |
| Grade 3-vs-Grade 4 |
9.583200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.066000E-02 |
| Normal-vs-ccB subtype |
4.07159999999962E-05 |
| ccA subtype-vs-ccB subtype |
4.760100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.176900E-04 |
| Normal-vs-N1 |
2.573800E-02 |
| N0-vs-N1 |
6.603200E-01 |
|
|
